Cornell to co-lead NIH center for precision nutrition research

The Division of Nutritional Sciences and partner RTI International won a five-year, $23 million award to coordinate research for the NIH’s Nutrition for Precision Health study.

Paid home care workers go well beyond standard duties

A study also revealed that expanded duties, particularly emotional care, resulted in a higher perceived value of the workers’ contributions, which could help boost pay for home care workers.

Action Research Collaborative aiming for results – now

Professors Neil Lewis Jr. ’13 and Tashara Leak are leading the new Action Research Collaborative, which will serve as an institutional hub for cross-campus action research collaborations between Ithaca and New York City, and elsewhere.

Staff News

Flu, measles vaccines could help flatten COVID curve

While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.

Gillibrand visits CVM to promote pandemic legislation

U.S. Sen. Kirsten Gillibrand (D-New York) visited the College of Veterinary Medicine on Jan. 7 to discuss bipartisan legislation proposing to establish centers of excellence for pandemic response and prevention.

Best time for COVID vaccination in pregnancy may be now

COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine.

Portable prostate cancer test may help reach underserved men

Utilizing a test strip and small reader that return results in minutes, a faculty team’s proof-of-concept test could improve access by enabling more screening in community settings.

Lymphoma cell metabolism may provide new cancer target

Aggressive and relatively common lymphomas called diffuse large B cell lymphomas have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from Cornell researchers.

Researchers find promising new target for TB treatment

Mycobacterium tuberculosis, the hardy bacterial species that causes tuberculosis, has an unexpected vulnerability that future drugs may be able to exploit, according to a study from researchers at Weill Cornell Medicine.